Aaron G.L. Fletcher Cue Biopharma, Inc. (CUE) insider trading activity

Aaron G.L. Fletcher is Director of Cue Biopharma, Inc.. Currently has a direct ownership of 165,000 shares of CUE, which is worth approximately $265,650. The most recent transaction as insider was on Nov 24, 2020, when has been sold 6,548 shares (Common Stock) at a price of $12.64 per share, resulting in proceeds of $82,767. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 165K

0% 3M change

0% 12M change

Total Value Held $265,650

Aaron G.L. Fletcher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 24 2020	BUY Open market or private purchase	$82,767 $12.64 p/Share	6,548 Added 3.82%	165,000 Common Stock

Also insider at

SWKH

SWK Holdings Corp Financial Services

Director

TFFP

TFF Pharmaceuticals, Inc. Healthcare

Director

INAB

IN8BIO, INC. Healthcare

> 10% Shareholder

CGTX

COGNITION THERAPEUTICS INC Healthcare

Director

LTRN

Lantern Pharma Inc. Healthcare

> 10% Shareholder

AZTR

Azitra Inc

> 10% Shareholder

ACTU

ACTUATE THERAPEUTICS, INC.

Director

AGF